A carregar...
Augmentation of fibroblast proliferation by bleomycin.
Bleomycin-induced lung disease is characterized by fibroblast proliferation and pulmonary fibrosis. In these studies, we demonstrate that fibroblasts are relatively resistant to clinically relevant amounts (below 10(-4) U/ml) of bleomycin and that these levels of bleomycin augment fibroblast prolife...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1986
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423797/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2429990/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112695 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|